Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer

Weiwei Yi; Haiqing Shen; Dexi Sun; Yongchao Xu; Yujie Feng; Dongbing Li; Caixia Wang

doi:10.12659/MSM.934522

09 December 2021: Database Analysis

Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer

Weiwei Yi ^1ABCEF , Haiqing Shen ^2BC , Dexi Sun ^3BC , Yongchao Xu ^4BC , Yujie Feng ^1BC , Dongbing Li ^5BC , Caixia Wang ^1ABCEF*

DOI: 10.12659/MSM.934522

Med Sci Monit 2021; 27:e934522

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 3 Low expression of SLC26A4-AS1 is associated with poor overall survival and disease-specific survival in patients with breast cancer. (A) Overall survival. (B) Disease-specific survival.

Back to the Article

Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer

Your Privacy